Dr Michael Krasovitsky
Conjoint Senior Lecturer

Dr Michael Krasovitsky

FRACP (Medical Oncology) (2021)

MBBS (Hons) (2013)

Masters of International Public Health (2022)

BA (Languages) (Honours) (2009)

Diploma of child health (2015)

 

Medicine & Health
School of Clinical Medicine

Dr Michael Krasovitsky is a medical oncologist at St Vincent's Hospital Darlinghurst specialising in geriatric oncology, supportive care & toxicity management, liver malignancies, thyroid cancers, and cancers of unknown primary.  He is the chair of the Geriatric Oncology Multi-disciplinary service at St Vincent's.  He holds an MBBS with honours from the Australian National University, and has also completed higher training in biostatistics and epidemiology as part of a Masters of International Public Health through UNSW.  Dr Krasovitsky is chair of the Geriatric Oncology Emerging Experts and Researchers group (GOEER), as well as a member of the COSA Geriatric Oncology executive.  He is involved in a number of quality improvement initiatives locally and nationally, primarily focussing on end of life care, systemic therapy safety, and supportive care.  He is also involved in a number of research endeavours, with his primary focus being on providing optimal cancer care to older individuals with cancer. 

Phone
+61422654756
Location
370 Victoria St, Darlinghurst NSW 2010
  • Journal articles | 2022
    Krasovitsky M; Lee YC; Sim HW; Chawla T; Moore H; Moses D; Baker L; Mandel C; Kielar A; Hartery A; O'Malley M; Friedlander M; Oza AM; Wang L; Lheureux S; Wilson M, 2022, 'Interobserver and intraobserver variability of RECIST assessment in ovarian cancer', International Journal of Gynecological Cancer, vol. 32, pp. 656 - 661, http://dx.doi.org/10.1136/ijgc-2021-003319
    Journal articles | 2012
    Krasovitsky M; Kecskes Z, 2012, '1082 Blood Pressure and Amplitude Integrated Electroencephalography Correlations in Full Term Neonates with Hypoxic Ischaemic Encephalopathy', Archives of Disease in Childhood, vol. 97, pp. A310 - A310, http://dx.doi.org/10.1136/archdischild-2012-302724.1082
  • Conference Papers | 2020
    Sivakumaran T; Krasovitsky M; Freimund A; Chen Lee K; Webber K; So J; Norris C; Friedlander M; Mileshkin L; Au-Yeung G, 2020, '402 Treatment patterns post PARP inhibitor in epithelial ovarian cancer patients: results from an Australian, retrospective, multi-institute cohort study', in Poster, BMJ Publishing Group Ltd, presented at IGCS 2020 Annual Meeting Abstracts, http://dx.doi.org/10.1136/ijgc-2020-igcs.347

Dr Krasovitsky has experience in submitting for MRFF and NH&MRC grants, and is currently listed as an investigator on a number of grants in the field of geriatric oncology. 

Dr Krasovitsky is primarily involved in research in the following fields: 

1.   Geriatric Oncology & optimal care pathways for older individuals with cancer.

2.   Supportive care & toxicity management among patients with cancer. 

3.   Thyroid malignancies.

4.   Hepatic malignancies.

5.   Quality of life measurement and intervention amongst patients with cancer.